Literature DB >> 32107583

Comparison of Angio-CT and cone-beam CT-guided immediate radiofrequency ablation after transcatheter arterial chemoembolization for large hepatocellular carcinoma.

Hongjun Yuan1, Xin Li1, Xiaomei Tian1, Kan Ji1, Fengyong Liu2.   

Abstract

PURPOSE: To evaluate the rapeutic effectiveness of Angio-CT or cone-beam CT (CBCT)-guided immediate radiofrequency ablation (RFA) after transcatheter arterial chemoembolization (TACE) for large hepatocellular carcinoma (HCC).
METHODS: 117 large HCC patients (mean maximum diameter: 9.3 cm; range 5.3-17.7 cm) were retrospective studied and divided into Angio-CT group (n = 66 cases), CBCT group (n = 21 cases), and single TACE group (n = 30 cases) according to treatment (Angio-CT/CBCT-guided immediate RFA after TACE, single TACE, respectively). The operative time, effective radiation dose, local-regional tumor responses, overall survival (OS), and progression‑free survival (PFS) time and complications were recorded.
RESULTS: The operative time and effective radiation dose of Angio-CT group and CBCT group were higher than those of TACE group (P < 0.01). The local-regional tumor responses on 1-month follow-up MRI (complete response + partial response) of Angio-CT group and CBCT group were 100%, which were significantly higher than that of single TACE group (76.7%, P < 0.05). There was no significant difference in local-regional tumor responses of 1-month follow-up between Angio-CT group and CBCT group (P = 0.831). The median PFS and OS time of Angio-CT group were 14.7 ± 1.43 months and 18.21 ± 0.88 months, CBCT group were 13.9 ± 1.53 months and 17.87 ± 1.78 months, TACE group were 10.4 ± 1.21 months and 12.87 ± 0.91 months, respectively. No procedure-related major complications occurred.
CONCLUSIONS: MIYABI Angio-CT or CBCT-guided immediate RFA after TACE for large HCC both have more effective than single TACE. The former is worth popularizing, due to its advantages of convenience, shorter operative time, and less radiation dose for doctors.

Entities:  

Keywords:  C-arm cone-beam CT; Large hepatocellular carcinoma; MIYABI Angio-CT; Radiofrequency ablation; Transcatheter arterial chemoembolization

Mesh:

Year:  2020        PMID: 32107583     DOI: 10.1007/s00261-020-02462-1

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  3 in total

1.  Single medium-sized hepatocellular carcinoma treated with sequential conventional transarterial chemoembolization (cTACE) and microwave ablation at 4 weeks versus cTACE alone: a propensity score.

Authors:  Zi-Yi Zhu; Mu Yuan; Pei-Pei Yang; Bo Xie; Jian-Zhu Wei; Zhong-Qiang Qin; Zhen Qian; Zhao-Ying Wang; Long-Fei Fan; Jing-Yu Qian; Yu-Lin Tan
Journal:  World J Surg Oncol       Date:  2022-06-10       Impact factor: 3.253

2.  Short-term outcomes of radiofrequency ablation for hepatocellular carcinoma using cone-beam computed tomography for planning and image guidance.

Authors:  Xue-Song Yao; Dong Yan; Xian-Xian Jiang; Xiao Li; Hui-Ying Zeng; Huai Li
Journal:  World J Clin Cases       Date:  2021-03-06       Impact factor: 1.337

3.  Initial Incomplete Thermal Ablation Is Associated With a High Risk of Tumor Progression in Patients With Hepatocellular Carcinoma.

Authors:  Jie Tan; Tian Tang; Wei Zhao; Zi-Shu Zhang; Yu-Dong Xiao
Journal:  Front Oncol       Date:  2021-10-18       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.